Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trialFeng Wang, Rui‐Hua Xu, Ying Jin et al.|Nature Medicine|2024Cited by 162
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratioXiaoli Wei, Rui‐Hua Xu, Feng‐Hua Wang et al.|BMC Cancer|2015Cited by 160
Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancerZhan‐Hong Chen, Feng Wang|Journal of Experimental & Clinical Cancer Research|2019Cited by 70
STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancerYao Cui, Shanshan Li, Yunyun Li et al.|Oncology Reports|2016Cited by 58
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumorsXiaoli Wei, Rui‐Hua Xu, Chao Ren et al.|Cancer Communications|2020Cited by 54